Literature DB >> 12414967

Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Upma Gulati1, Chi-Ching Hwang, Lalitha Venkatramani, Shelly Gulati, Stephen J Stray, Janis T Lee, W Graeme Laver, Alexey Bochkarev, Adam Zlotnick, Gillian M Air.   

Abstract

We have characterized monoclonal antibodies raised against the neuraminidase (NA) of a Sydney-like influenza virus (A/Memphis/31/98, H3N2) in a reassortant virus A/NWS/33(HA)-A/Mem/31/98(NA) (H1N2) and nine escape mutants selected by these monoclonal antibodies. Five of the antibodies use the same heavy chain VDJ genes and may not be independent. Another antibody, Mem5, uses the same V(H) and J genes with a different D gene and different isotype. Sequence changes in escape mutants selected by these antibodies occur in two loops of the NA, at amino acid 198, 199, 220, or 221. These amino acids are located on the opposite side of the NA monomer to the major epitopes found in N9 and early N2 NAs. Escape mutants with a change at 198 have reduced NA activity compared to the wild-type virus. Asp198 points toward the substrate binding pocket, and we had previously found that a site-directed mutation of this amino acid resulted in a loss of enzyme activity (M. R. Lentz, R. G. Webster, and G. M. Air, Biochemistry 26:5351-5358, 1987). Mutations at residue 199, 220, or 221 did not alter the NA activity significantly compared to that of wild-type NA. A 3.5-A structure of Mem5 Fab complexed with the Mem/98 NA shows that the Mem5 antibody binds at the sites of escape mutation selected by the other antibodies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414967      PMCID: PMC136895          DOI: 10.1128/jvi.76.23.12274-12280.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Kabat Database and its applications: future directions.

Authors:  G Johnson; T T Wu
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

3.  Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.

Authors:  Janis T Lee; Gillian M Air
Journal:  Virology       Date:  2002-09-01       Impact factor: 3.616

4.  The structure of the complex between influenza virus neuraminidase and sialic acid, the viral receptor.

Authors:  J N Varghese; J L McKimm-Breschkin; J B Caldwell; A A Kortt; P M Colman
Journal:  Proteins       Date:  1992-11

5.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

6.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

7.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

8.  Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains.

Authors:  W G Laver
Journal:  Virology       Date:  1978-05-01       Impact factor: 3.616

9.  Influenza A virus neuraminidase: regions of the protein potentially involved in virus-host interactions.

Authors:  T G Fanning; A H Reid; J K Taubenberger
Journal:  Virology       Date:  2000-10-25       Impact factor: 3.616

10.  Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies.

Authors:  W Gerhard; J Yewdell; M E Frankel; R Webster
Journal:  Nature       Date:  1981-04-23       Impact factor: 49.962

View more
  47 in total

1.  Discordant antigenic drift of neuraminidase and hemagglutinin in H1N1 and H3N2 influenza viruses.

Authors:  Matthew R Sandbulte; Kim B Westgeest; Jin Gao; Xiyan Xu; Alexander I Klimov; Colin A Russell; David F Burke; Derek J Smith; Ron A M Fouchier; Maryna C Eichelberger
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Epitope analysis for influenza vaccine design.

Authors:  Enrique T Muñoz; Michael W Deem
Journal:  Vaccine       Date:  2005-01-19       Impact factor: 3.641

3.  Influenza virus neuraminidase contributes to secondary bacterial pneumonia.

Authors:  Ville T Peltola; K Gopal Murti; Jonathan A McCullers
Journal:  J Infect Dis       Date:  2005-06-08       Impact factor: 5.226

Review 4.  Vaccinology in the genome era.

Authors:  C Daniela Rinaudo; John L Telford; Rino Rappuoli; Kate L Seib
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

5.  Allele-specific nonstationarity in evolution of influenza A virus surface proteins.

Authors:  Anfisa V Popova; Ksenia R Safina; Vasily V Ptushenko; Anastasia V Stolyarova; Alexander V Favorov; Alexey D Neverov; Georgii A Bazykin
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-02       Impact factor: 11.205

Review 6.  Biosensor-based epitope mapping of antibodies targeting the hemagglutinin and neuraminidase of influenza A virus.

Authors:  Zhu Guo; Jason R Wilson; Ian A York; James Stevens
Journal:  J Immunol Methods       Date:  2018-07-24       Impact factor: 2.303

7.  Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution.

Authors:  Kim B Westgeest; Miranda de Graaf; Mathieu Fourment; Theo M Bestebroer; Ruud van Beek; Monique I J Spronken; Jan C de Jong; Guus F Rimmelzwaan; Colin A Russell; Albert D M E Osterhaus; Gavin J D Smith; Derek J Smith; Ron A M Fouchier
Journal:  J Gen Virol       Date:  2012-06-20       Impact factor: 3.891

8.  Influenza A Virus Studies in a Mouse Model of Infection.

Authors:  Laura Rodriguez; Aitor Nogales; Luis Martínez-Sobrido
Journal:  J Vis Exp       Date:  2017-09-07       Impact factor: 1.355

9.  Downregulating viral gene expression: codon usage bias manipulation for the generation of novel influenza A virus vaccines.

Authors:  Steven F Baker; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Future Virol       Date:  2015-06       Impact factor: 1.831

Review 10.  Towards a sane and rational approach to management of Influenza H1N1 2009.

Authors:  William R Gallaher
Journal:  Virol J       Date:  2009-05-07       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.